[Regression of an osteolytic lesion in a patient with multiple myeloma treated with clodronate after a successful therapy with bortezomib-based regimen]. [electronic resource]
Producer: 20110805Description: 216-20 p. digitalISSN:- 0862-495X
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Density Conservation Agents -- therapeutic use
- Boronic Acids -- administration & dosage
- Bortezomib
- Clodronic Acid -- therapeutic use
- Femur -- diagnostic imaging
- Humans
- Male
- Multiple Myeloma -- complications
- Osteolysis -- complications
- Pyrazines -- administration & dosage
- Radiography
- Recurrence
- Remission Induction
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.